Sector: Qualified Accountancy & Financial Management

Location: Central London

Type: Permanent

Ref: BBBH72443_1776247439

Salary: £90000.00 - £110000.00 per annum + plus equity

Corporate Development Manager

Location: London (Central)

Salary: £90,000 - £110,000 base + equity

Travel: 1 day per week (UK & Ireland)

Hybrid - 2 days in the office, 3 days WFH

We are working with a high-growth, PE-backed healthcare platform at a pivotal stage of its journey, executing an ambitious and well-funded buy-and-build strategy across the UK & Ireland.

With a strong pipeline of acquisition targets already identified, the business is now looking to appoint a Corporate Development Director to play a leading role in driving and executing its M&A agenda.

This individual will be instrumental in helping scale the platform through the acquisition of high-quality assets, working closely with the C-suite and investor group to deliver on its growth strategy. This is a high-impact, front-office role, offering end-to-end exposure across the deal life-cycle, from origination and evaluation through to execution and integration.

You will be at the centre of strategic decision-making, helping shape the direction of the business as it continues to expand.

The role offers a rare opportunity to join a business early in its buy-and-build journey, where you will have genuine influence over deal activity, portfolio growth, and long-term value creation, with equity upside aligned to successful execution.

We are looking for someone with hands-on experience transacting in the lower mid-market (£2m- £5m deal size). Experience in acquiring nurseries, special needs care homes, or nursing homes within a multi-site environment would be preferred.

Key Responsibilities

Deal Origination & Execution

• Identify and engage with independent Healthcare practices across the UK & Ireland


• Build relationships with brokers, advisors, and practice owners


• Support pipeline development aligned with the group's acquisition strategy

Financial Analysis & Due Diligence

• Lead financial modelling and valuation analysis


• Assess the commercial viability of acquisition targets


• Run and coordinate the full due diligence process (financial, operational, commercial)


• Work closely with external advisors where required

Transaction Management

• Draft and negotiate Letters of Intent (LOIs)


• Prepare investment papers and presentations for the Investment Committee


• Support deal structuring and completion

Stakeholder Management

• Partner with the CFO, CEO, and investors


• Liaise with legal, financial, and operational advisors


• Work closely with integration teams post-acquisition

Candidate Profile

Essential:

• ACA or equivalent qualified accounting qualification (Top 10 / Big 4 preferred)


• Strong academics


• Background in:


• M&A / Transaction Services / Corporate Finance


• Ideally, exposure to lower mid-market deals


• Experience in healthcare advisory or multi-site environments is highly desirable


• Proven ability to:


• Lead due diligence processes


• Build financial models


• Present investment cases

Highly Desirable:

• Experience in buy-and-build environments


• Exposure to private equity-backed businesses


• Track record of executing deals end-to-end

What Success Looks Like

• Successfully identifying and executing high-quality acquisitions


• Delivering robust financial and commercial analysis


• Building a strong deal pipeline across the UK & Ireland


• Playing a key role in scaling a high-growth healthcare platform

Why Join?

• Be part of a high-growth, entrepreneurial healthcare platform


• Work directly with senior leadership and investors


• Gain exposure to end-to-end deal execution


• Participate in the equity upside of a scaling platform


• Operate in a highly acquisitive, PE-style environment

This is a rare opportunity for a qualified accountant, trained M&A professional to step into a front-line corporate development role within a fast-scaling buy-and-build healthcare platform - with real ownership, deal exposure, and equity upside.